GPIbα is required for platelet-mediated hepatic thrombopoietin generation
- 9 August 2018
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 132 (6), 622-634
- https://doi.org/10.1182/blood-2017-12-820779
Abstract
Thrombopoietin (TPO), a hematopoietic growth factor produced predominantly by the liver, is essential for thrombopoiesis. Prevailing theory posits that circulating TPO levels are maintained through its clearance by platelets and megakaryocytes via surface c-Mpl receptor internalization. Interestingly, we found a two- to threefold decrease in circulating TPO in GPIbα−/− mice compared with wild-type (WT) controls, which was consistent in GPIbα-deficient human Bernard-Soulier syndrome (BSS) patients. We showed that lower TPO levels in GPIbα-deficient conditions were not due to increased TPO clearance by GPIbα−/− platelets but rather to decreased hepatic TPO mRNA transcription and production. We found that WT, but not GPIbα−/−, platelet transfusions rescued hepatic TPO mRNA and circulating TPO levels in GPIbα−/− mice. In vitro hepatocyte cocultures with platelets or GPIbα-coupled beads further confirm the disruption of platelet-mediated hepatic TPO generation in the absence of GPIbα. Treatment of GPIbα−/− platelets with neuraminidase caused significant desialylation; however, strikingly, desialylated GPIbα−/− platelets could not rescue impaired hepatic TPO production in vivo or in vitro, suggesting that GPIbα, independent of platelet desialylation, is a prerequisite for hepatic TPO generation. Additionally, impaired hepatic TPO production was recapitulated in interleukin-4/GPIbα–transgenic mice, as well as with antibodies targeting the extracellular portion of GPIbα, demonstrating that the N terminus of GPIbα is required for platelet-mediated hepatic TPO generation. These findings reveal a novel nonredundant regulatory role for platelets in hepatic TPO homeostasis, which improves our understanding of constitutive TPO regulation and has important implications in diseases related to GPIbα, such as BSS and auto- and alloimmune-mediated thrombocytopenias.This publication has 94 references indexed in Scilit:
- The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapiesJCI Insight, 2011
- Thrombopoietin and Platelet Production in Chronic Immune ThrombocytopeniaHematology/Oncology Clinics of North America, 2009
- The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboonsThrombosis and Haemostasis, 2008
- The Pathogenesis of Chronic Immune Thrombocytopenic PurpuraSeminars in Hematology, 2007
- The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosisProceedings of the National Academy of Sciences of the United States of America, 2006
- Differential Expression of Novel Potential Regulators in Hematopoietic Stem CellsPLoS Genetics, 2005
- Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITPBlood, 2004
- Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndromeBlood, 2002
- The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesisBritish Journal of Haematology, 1996
- Demonstration and Some Properties of Human Thrombopoietin in Thrombocythaemic SeraActa Haematologica, 1958